Abstract
Objectives
Little information is available regarding the use of Chinese herbal medicine to treat mastitis. This study evaluated the prescription patterns of Chinese herbal medicine products in women with mastitis in Taiwan.
Design
This is a population-based cross-sectional study. Setting. 8,531 women aged 20–49 years, who received a diagnosis of mastitis between 2004 and 2013, were identified from the Longitudinal Health Insurance Database in Taiwan. We collected data on demographic characteristics, including age, monthly insurance premium, and urbanization level. The ten most Chinese herbal medicines prescribed for mastitis were assessed, including frequency, percentage, average daily dose, and average duration of prescription. Main outcome measures. We analysed the ten most single Chinese herbs and Chinese herbal formulae prescribed for mastitis.
Results
Overall, 437 (5.1%) women received Chinese herbal medicine to treat mastitis. Mai Men Dong (Ophiopogon japonicus (Thunb.) Ker Gawl.; 22.3%), Pu Gong Yin (Taraxacum mongolicum Hand.-Mazz.; 7.8%), and Wang Bu Liu Xing (Vaccaria hispanica (Mill.) Rauschert; 3.5%) were three of the most commonly prescribed single Chinese herbs for mastitis. Xian-Fang-Huo-Ming-Yin (18.2%), Jia-Wei-Xiao-Yao-San (9.1%), and Chai-Hu-Shu-Gan-San (8.4%) were three of the most commonly prescribed Chinese herbal formulae.
Conclusion
Xian-Fang-Huo-Ming-Yin can clear heat, detoxify body, alleviate swelling, activate blood, and relieve pain. It was the most frequently prescribed Chinese herbal formula in patients with mastitis.
1. Introduction
Mastitis is an inflammation of the breast, which may or may not involve an infection. It is usually related to lactation. The World Health Organization reported that incidence of mastitis in lactating women ranged from 3% to 33% [1]; it usually occurs in the first six weeks postpartum, and the incidence gradually declines thereafter [2]. The major causes of mastitis are milk stasis and infection [1]; other factors include genetic factors, immune factors, trauma, etc. However, women with nonlactational causes of mastitis are less common [3]. A previous study reported the frequency of nonlactational mastitis among biopsies for benign breast diseases to be 3% [4].
Mastitis diagnosis is usually based on clinical symptoms and signs, such as breast pain, heat, swelling, fever, and chills [2]. In 946 breastfeeding women, Foxman et al. [5] found that the most common mastitis symptoms were breast tenderness (98%), malaise (87%), fever (82%), chills (78%), redness (78%), and a hot spot on the affected breast (62%).
Mastitis should be treated immediately, as a delay in treatment or inappropriate management can lead to breast abscess, which occurs in 5 to 11% of mastitis cases [6]. The treatments for mastitis usually include effective milk removal, counselling, as well as antibiotic and symptomatic treatment. Other therapies include the use of cabbage leaves and herbal treatment [1]. Cabbage leaves, with both antibiotic and anti-irritant properties, can reduce pain and increase breastfeeding duration [1, 7]. Gleditsiae Fructus extract has also been reported to be effective in treating mastitis [1]. Wu et al. [8] found that Taraxaci Herba, Glycyrrhizae Radix et Rhizoma, Paeoniae Radix Alba, and Citri Reticulatae Semen were the most commonly prescribed Chinese medicines for mastitis.
Mastitis and breast abscess are known as “Ru Yong” (breast carbuncle) in Chinese medicine. Ge Zhi Yu Lun, an ancient Chinese medical text, states that the breasts itself belong to the stomach meridian, and the nipples belong to the liver meridian. If a nursing mother is angry, depressed, or eats excessive amounts of greasy food, the Qi will stagnate and milk ducts will become blocked, causing milk stasis, which may transform into heat and possibly also an abscess. If the infant has interior heat, they might pass the heat to the mother through breastfeeding, which can cause breast lumps [9]. Chinese medicine is widely used in Taiwan. However, very few studies have investigated the application of Chinese herbal medicine (CHM) in the treatment of mastitis. Therefore, the aim of the study is to assess the patterns of CHM prescriptions to treat mastitis in women in Taiwan from the Longitudinal Health Insurance Database (LHID).
2. Materials and Methods
2.1. Data Source and Study Population
This retrospective, population-based, cross-sectional study used data from the Longitudinal Health Insurance Database (LHID), where one million beneficiaries were randomly selected from the National Health Insurance Research Database (NHIRD) in Taiwan. The LHID sample and all NHIRD enrollees had no differences in age, gender, or average insured payroll-related premiums. The LHID database contains information about outpatient visits, hospital admissions, prescriptions, disease status, and patient demographics. To protect confidentiality, all identification numbers of patients and medical institutions were encrypted and maintained by Taiwan's National Health Research Institutes before extracting and analysing data. The diagnostic codes used in the LHID were according to the International Classification of Disease, 9th Revision, Clinical Modification (ICD-9-CM) coding. In addition, this study was approved by the Institutional Review Board of Taichung Veterans General Hospital (IRB No. CE15069A-3, Taiwan), and the requirement for informed consent was waived.
A sample of one million patients was randomly selected from the National Health Insurance Research Database (NHIRD). All patients without mastitis (ICD-9-CM code 611.0) were excluded (n = 989,359). A total of 10,641 women who received a diagnosis of mastitis (ICD-9-CM code 611.0) between 2004 and 2013 were identified. We excluded patients aged <20 or ≥50 years of age (n = 1,900) and those who were diagnosed with mastitis before 2004 (n = 210). The date of the initial mastitis diagnosis was defined as the index date. The final sample included 8,531 newly diagnosed patients with mastitis who were classified into those who did and did not use CHM to treat mastitis. Figure 1 shows a flow diagram of the study selection process.
Figure 1.
Flow diagram of sample selection. CHM, Chinese herbal medicine.
2.2. Chinese Herbal Medicine Use
The primary variable of interest was whether patients received CHM treatment for mastitis (ICD-9-CM code 611.0). Chinese herbal medicine products are prescribed for outpatient treatment by traditional Chinese medicine (TCM) physicians according to Taiwan's National Health Insurance program guidelines. Chinese herbal medicine use was defined as patients who had been prescribed CHM for treating mastitis at least once after the index date, whereas non-CHM use was defined as those who did not visit TCM physicians. The possible pharmacological effects of single Chinese herbs were searched from scientific literature published between July 2006 and January 2019, and the retrieval database is PubMed.
2.3. Variables
The demographic variables compared between the CHM and non-CHM groups were age at mastitis diagnosis, monthly insurance premium, and urbanization level.
Age was classified into groups of 20−29, 30−39, and 40−49. Individual monthly insurance premium was determined according to work salary, and premiums (in Taiwan dollars (TWD)) were classified into ≥45,801, 28,801–45,800, 15,841–28,800, <15,840, and dependent groups. The dependent group included students, stay-at-home parents, and family members without a fixed salary. The urbanization level was classified as urban, suburban, and rural.
2.4. Statistical Analyses
Distribution of the characteristics between patients with mastitis, with and without CHM, was examined using chi-square or Fisher's exact tests for categorical variables and Student's t-test for continuous variables. The prescription patterns of the 10 most prescribed single Chinese herbs and Chinese herbal formulae for mastitis treatment were analysed, including frequencies, percentages, average use duration (days/visit), and average daily dose (g). The threshold for statistical significance was set at p < 0.05. All analyses were conducted using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA).
3. Results
We included 8,531 women who were newly diagnosed with mastitis between 2004 and 2013. Of these, 437 (5.1%) were CHM users and 8,094 (94.8%) were non-CHM users. The demographic characteristics of CHM users and nonusers are shown in Table 1. The mean age at diagnosis was 33.3 and 32.9 years in CHM and non-CHM users, respectively. The monthly insurance premium results revealed that over 60% of participants belong to the dependent group, which included students, stay-at-home parents, and those without a fixed salary. There was no difference in the urbanization level between the two groups.
Table 1.
Demographic characteristics of the patients with mastitis by Chinese herbal medicine use.
CHM user (n = 437) | Non-CHM user (n = 8,094) | p | |||
---|---|---|---|---|---|
Age at diagnosed mastitis (years), mean (SD) | 33.3 | (5.7) | 32.9 | (6.8) | 0.173 |
20–29 | 110 | (25.2) | 2,648 | (32.7) | <0.001 |
30–39 | 267 | (61.1) | 4,011 | (49.6) | |
40–49 | 60 | (13.7) | 1,435 | (17.7) | |
Monthly insurance premium (TWD) | 0.014 | ||||
≥45,801 | 8 | (1.8) | 139 | (1.7) | |
28,801–45,800 | 17 | (3.9) | 349 | (4.3) | |
15,841–28,800 | 59 | (13.5) | 1,460 | (18.0) | |
<15,840 | 48 | (11.0) | 1,155 | (14.3) | |
Dependent | 305 | (69.8) | 4,991 | (61.7) | |
Urbanization level | 0.257 | ||||
Urban | 276 | (63.2) | 4,896 | (60.5) | |
Suburban | 63 | (14.4) | 1,097 | (13.5) | |
Rural | 98 | (22.4) | 2,101 | (26.0) |
CHM, Chinese herbal medicine; TWD, Taiwan dollars.
The prescription patterns of CHM and the 10 most prescribed single Chinese herbs and Chinese herbal formulae for mastitis are presented in Tables 2 and 3, respectively. Mai Men Dong (Ophiopogon japonicus (Thunb.) Ker Gawl.; 22.3%), Pu Gong Yin (Taraxacum mongolicum Hand.-Mazz.; 7.8%), and Wang Bu Liu Xing (Vaccaria hispanica (Mill.) Rauschert; 3.5%) were three of the most commonly prescribed single Chinese herbs for mastitis. The most commonly prescribed Chinese herbal formula was Xian-Fang-Huo-Ming-Yin (18.2%), followed by Jia-Wei-Xiao-Yao-San (9.1%) and Chai-Hu-Su-Gan-San (8.4%). Furthermore, Jin Yin Hua (Lonicera japonica Thunb.), Tian Hua Fen (Trichosanthes kirilowii Maxim.), Zhe Bei Mu (Fritillaria thunbergii Miq.), Xiang Fu (Cyperus rotundus L.), and Pu Gong Ying (Taraxacum mongolicum Hand.-Mazz.) were not only part of the ten most single Chinese herbs prescribed for mastitis but also part of the ingredients of the ten most formulae prescribed for mastitis. The Chinese herbal medicine effects are summarized in Tables 2 and 3; most of these Chinese herbs can clear heat, resolve toxin, reduce swelling, and relieve pain. The possible pharmacological effects of the 10 most prescribed single Chinese herbs for mastitis are summarized in Table 2; most of these Chinese herbs have anti-inflammation and analgesic effects. The average duration for prescription of single Chinese herbs and Chinese herbal formulae are between 5.0 and 8.2 days.
Table 2.
Ten most prescribed single Chinese herbs for mastitis (total prescription numbers = 7,693).
CHM | Frequency | % | Average duration for prescription (days/visit) | Average daily dose (g) | CHM effects | Possible pharmacological effects | Reference | ||
---|---|---|---|---|---|---|---|---|---|
Chinese name | Scientific name | English name | |||||||
Mai Men Dong | Ophiopogon japonicus (Thunb.) Ker Gawl. | Dwarf lilyturf root | 63 | 22.3 | 7.0 | 1.2 | Nourishes vital essence, removes heat from the heart, and removes dryness from the lung | Anti-inflammation | [10] |
Pu Gong Yin | Taraxacum mongolicum Hand.-Mazz. | Mongolian dandelion herb | 22 | 7.8 | 6. | 1.8 | Clears heat, resolves toxins, and expels node | Anti-inflammation, analgesic effects | [11] |
Wang Bu Liu Xing | Vaccaria hispanica (Mill.) Rauschert | Cowherb seed | 10 | 3.5 | 6.3 | 1.0 | Activates blood, promotes milk secretion, disperses swelling, and reduces sores | Anti-inflammation, analgesic effects | [12] |
Xiang Fu | Cyperus rotundus L. | Cyperus rhizome | 9 | 3.2 | 6.7 | 1.1 | Soothes the liver and rectifies Qi | Anti-inflammation | [13] |
Chuan Lian Zi | Melia azedarach L. | Sichuan chinaberry fruit | 8 | 2.8 | 6.0 | 1.3 | Rectifies Qi, relieves pain, and clears liver-heat | Anti-inflammation, analgesic effects | [14] |
Lu Lu Tong | Liquidambar formosana Hance | Beautiful sweetgum fruit | 8 | 2.8 | 6.1 | 1.3 | Dispels wind and frees the channels | Anti-inflammation | [15] |
Yu Jin | Curcuma phaeocaulis Valeton | Curcuma root | 7 | 2.5 | 6.9 | 1.0 | Promotes blood circulation for relieving pain, invigorates the flow of Qi for soothing depressed liver, and clears away heat in the blood and heart | Anti-inflammation, analgesic effects | [16] |
Tian Hua Fen | Trichosanthes kirilowii Maxim. | Trichosanthes root | 6 | 2.1 | 5.7 | 1.1 | Clears heat and engenders fluid, disperses swelling, and expels pus | Anti-inflammation | [17] |
Zhe Bei Mu | Fritillaria thunbergii Miq. | Thunberg fritillary bulb | 6 | 2.1 | 6.2 | 1.4 | Resolves heat-phlegm | Inhibits IL-6, IL-8, TNF-alpha, and MAPK pathways | [18] |
Jin Yin Hua | Lonicera japonica Thunb. | Honeysuckle flower bud | 6 | 2.1 | 6.3 | 2.2 | Dispels wind-heat and removes heat and toxic substances | Antiviral | [19] |
CHM, Chinese herbal medicine.
Table 3.
Ten most prescribed Chinese herbal formulae for mastitis (total prescription numbers = 7,693).
Chinese herbal formulae name | Ingredients | Frequency | % | Average duration for prescription (days/visit) | Average daily dose (g) | Effects |
---|---|---|---|---|---|---|
Xian Fang Huo Ming Yin | Lonicera japonica Thunb., Fritillaria thunbergii Miq., Gleditsia sinensis Lam., Angelica sinensis (Oliv.) Diels, Trichosanthes kirilowii Maxim., Boswellia sacra Flueck., Saposhnikovia divaricata (Turcz.) Schischk., Paeonia lactiflora Pall., Commiphora myrrha (Nees) Engl., Manis pentadactyla Linnaeus, Citrus reticulata Blanco, Glycyrrhiza uralensis Fisch. | 28 | 18.2 | 6.4 | 4.5 | Clears heat, resolves toxins, disperses swelling, promotes suppuration, invigorates blood, and relieves pain |
Jia Wei Xiao Yao San | Paeonia suffruticosa Andrews, Gardenia jasminoides J.Ellis, Paeonia lactiflora Pall., Bupleurum chinense DC., Mentha haplocalyx Briq., Angelica sinensis (Oliv.) Diels, Atractylodes macrocephala Koidz., Poria cocos (Schwein.) F.A.Wolf, Glycyrrhiza uralensis Fisch., Zingiber officinale Roscoe | 14 | 9.1 | 6.6 | 6.9 | Clears heat to cool the blood, soothes the liver, and releases depression |
Chai Hu Shu Gan San | Bupleurum chinense DC., Ligusticum striatum DC., Cyperus rotundus L., Paeonia lactiflora Pall., Citrus reticulata Blanco, Glycyrrhiza uralensis Fisch., Citrus × aurantium L. | 13 | 8.4 | 6.3 | 3.4 | Soothes the liver and regulates Qi |
Xiao Yao San | Paeonia lactiflora Pall., Bupleurum chinense DC., Mentha haplocalyx Briq., Angelica sinensis (Oliv.) Diels, Atractylodes macrocephala Koidz., Poria cocos (Schwein.) F.A.Wolf, Glycyrrhiza uralensis Fisch., Zingiber officinale Roscoe | 8 | 5.2 | 8.2 | 5.2 | Soothes the liver and resolves constraint, nourishes blood, and fortifies the spleen |
Shi Liu Wei Liu Qi Yin | Angelica sinensis (Oliv.) Diels, Aucklandia lappa DC., Ligusticum striatum DC., Magnolia officinalis Rehder & E.H.Wilson, Platycodon grandiflorus (Jacq.) A.DC., Areca catechu L., Astragalus membranaceus (Fisch.) Bunge, Citrus × aurantium L., Panax ginseng C.A.Mey., Lindera aggregata (Sims) Kosterm., Cinnamomum cassia (L.) J.Presl, Perilla frutescens (L.) Britton, Angelica dahurica (Hoffm.) Benth. & Hook.f. ex Franch. & Sav., Saposhnikovia divaricata (Turcz.) Schischk., Glycyrrhiza uralensis Fisch., Paeonia lactiflora Pall. | 4 | 2.6 | 6.2 | 6.5 | Promotes the movement of Qi and blood, disperses stagnation, expels pus, and dissipates swelling |
Wu Wei Xiao Du Yin | Lonicera japonica Thunb., Taraxacum mongolicum Hand.-Mazz., Chrysanthemum indicum L., Viola philippica Cav., Malva verticillata L. | 4 | 2.6 | 8.2 | 4.9 | Clears heat, relieves toxicity, cools the blood, reduces swelling, and reduces external carbuncles and furuncles |
Su Wu Tang | Ligusticum striatum DC., Angelica sinensis (Oliv.) Diels, Paeonia lactiflora Pall., Rehmannia glutinosa (Gaertn.) DC. | 4 | 2.6 | 6.5 | 4.6 | Tonifies and harmonizes blood |
Shao Yao Gan Cao Tang | Paeonia lactiflora Pall., Glycyrrhiza uralensis Fisch. | 4 | 2.6 | 6.2 | 4.5 | Relaxes tension to relieve pain |
Xiao Chai Hu Tang | Bupleurum chinense DC., Scutellaria baicalensis Georgi, Panax ginseng C.A.Mey., Pinellia ternata (Thunb.) Makino, Glycyrrhiza uralensis Fisch., Zingiber officinale Roscoe, Ziziphus jujuba Mill. | 3 | 2.0 | 5.0 | 6.0 | Harmonizes and releases the lesser yang (shaoyang) |
Si Ni San | Bupleurum chinense DC., Citrus × aurantium L., Paeonia lactiflora Pall., Glycyrrhiza uralensis Fisch. | 3 | 2.0 | 5.7 | 4.2 | Soothes the liver and regulates the spleen |
4. Discussion
Mastitis is a common problem faced by breastfeeding women. However, this is the first study to investigate TCM prescription patterns among female patients with mastitis in Taiwan. For this, we used data from the LHID on prescriptions made by registered TCM practitioners who had been trained by the Health Promotion Administration as breastfeeding instructors. Our results showed a higher proportion of CHM use for mastitis treatment in women aged 30–39 years. This may be partially due to an increasing proportion of mothers with advanced age at childbirth and they may suffer from mastitis during breastfeeding. According to the annual report of the Health Promotion Administration, Taiwanese women gave birth to their first child at an average age of 27.4 years in 2004 and 30.5 years in 2014. In addition, since 2009, more than half of the women giving birth in Taiwan have been aged between 30 and 40 years [20].
In TCM, “Ru Yong” is caused by liver Qi depression, stomach heat, infections, inadequate breastfeeding, or Qi counterflow during pregnancy, which can lead to milk accumulation. In the initial stage of treatment, the aim is to relieve symptoms, mainly by soothing the liver and regulating Qi, clearing stomach fire, dispersing nodules, and letting the milk flow. If mastitis progresses to an abscess, the aim is to expel pus and toxins.
The three most prescribed Chinese herbal formulae were Xian-Fang-Huo-Ming-Yin (18.2%), Jia-Wei-Xiao-Yao-San (9.1%), and Chai-Hu-Shu-Gan-San (8.4%). The three most prescribed Chinese herbs were Mai Men Dong (22.3%), Pu Gong Yin (7.8%), and Wang Bu Liu Xing (3.5%).
Xian-Fang-Huo-Ming-Yin is a well-known Chinese herbal formula that can clear heat, detoxify body, alleviate swelling, activate blood flow, and relieve pain. It has been widely applied to treat sores, carbuncles, and abscesses. Although it is commonly prescribed for mastitis, no research has yet documented the effect of Xian-Fang-Huo-Ming-Yin on mastitis. The formula is composed of 12 single Chinese herbs. Among them, Jin Yin Hua (Lonicera japonica Thunb.) has been reported to have an antiviral effect [19], and Tian Hua Fen (Trichosanthes kirilowii Maxim.) has been reported to have anti-inflammatory effects and the ability to clear heat, alleviate swelling, and expel pus [17, 21]. Zhe Bei Mu (Fritillaria thunbergii Miq.) is thought to inhibit interleukin-6, interleukin-8, tumour necrosis factor-α, and the mitogen-activated protein kinase pathway [18]; indeed, mastitis is characterized by increased interleukin-8 concentrations in milk [22]. It is worth noting that Xian-Fang-Huo-Ming-Yin does not contain Chuan Shan Jia (Manis pentadactyla Linnaeus) nowadays. Though it can stimulate lactation, disperse swelling, and expel pus, excessive hunting has led to becoming endangered. In 2000, the Department of Health in Taiwan banned the use of products obtained from protected species (e.g., pangolin, bear bile, musk, and Saiga antelope horn) from medical use [23]. The committee on Chinese Medicine and Pharmacy revealed that Wang Bu Liu Xing could replace Chuan Shan Jia to help increase lactation [24]. The Dean of the American College of Traditional Chinese Medicine, Steve Given, mentioned that there are 125 alternatives for Chuan Shan Jia, depending on the diagnosis, since alternatives of TCM could be composed of various products instead of a one-to-one replacement. Moreover, what was reasonable a few decades ago may not be reasonable today [25].
Jia-Wei-Xiao-Yao-San is usually prescribed to treat insomnia, depressive disorder, anxiety disorder, and functional dyspepsia [26, 27]. It can decrease serotonin and interleukin-6 and has been reported to have an antidepressant-like effect [28, 29]. Chai-Hu-Shu-Gan-San can soothe the liver and regulate Qi and is also used to treat anxiety and depression, especially poststroke depression and postpartum depression, according to Yan Sun's research [13, 30]. In addition, Chai Hu (Bupleurum chinense DC.), Xiang Fu (Cyperus rotundus L.), and Chuan Xiong (Ligusticum striatum DC.), which are part of the composition of Chai-Hu-Shu-Gan-San, also have anti-inflammatory effects [13]. Cooklin et al. [31] investigated the link between physical health, breastfeeding problems, and maternal mood and found that the presence of breastfeeding problems was associated with poorer maternal mood. Fallon et al. [32] reviewed the relationship between postpartum anxiety and infant-feeding outcomes, and their results indicated that postpartum anxiety increases breastfeeding difficulties. Webber and Benedict [33] investigated the relationship between inflammation, breastfeeding, and postpartum depression and reported a negative correlation between postpartum depression and breastfeeding. Furthermore, stress can cause inflammation and increase the risk of depression. According to the Ge Zhi Yu Lun, the classics of traditional Chinese medicine, the liver can regulate Qi and is associated with emotion. Emotion may cause the stagnation of Qi, resulting in milk stasis and mastitis. As a result, mastitis can be treated by soothing the liver and regulating Qi.
When it comes to the most prescribed Chinese herbs for mastitis, many of these prescription herbs are used to rectify Qi, clear heat, resolve toxins, disperse swelling, and relieve pain. The possible pharmacological effects of Chinese herbs are obtained from the scientific literature by PubMed and are listed in Table 2.
Mai Men Dong nourishes Yin and generates fluid and, therefore, is used as a typical treatment for Yin deficiency, dry mouth, fluid depletion, and constipation [34]. Women's constitution transferred throughout the perinatal period. A previous study revealed that Yin-Xu constitution worsened during pregnancy and did not recover at six months postpartum [35]. The use of Mai Men Dong may also ameliorate some postpartum physical symptoms, such as sweating, thirst, and constipation [36, 37]. Furthermore, Yi Xue Qi Yuan, an ancient Chinese medical text, describes that Mai Men Dong is also used to treat lactation. In addition, Mai Men Dong had been proved to have anti-inflammation effects [10].
Pu Gong Ying can clear heat toxins and relieve swelling. It has anti-inflammatory and analgesic effects and has been used to treat upper respiratory tract infections, urinary tract infections, hepatitis, and dyspepsia [11]. Wang Bu Liu Xing is effective in activating blood circulation and reducing swelling, has analgesic and anti-inflammatory effects [12], and is used to treat female mammary gland diseases and promote lactation.
Chuan Lian Zi (Melia azedarach L.), Lu Lu Tong (Liquidambar formosana Hance), and Yu Jin (Curcuma phaeocaulis Valeton) have anti-inflammatory effects [14–16]. Chuan Lian Zi and Yu Jin have analgesic effects [14, 16].
In this study, we found that the mastitis rate in Taiwan was much lower compared with that reported by previous studies. This underestimation might be due to the use of health care services. In Taiwan, women with mastitis usually opt for Western medicine, breast massage, or consultation with international board-certified lactation consultants. Among these treatments, the National Health Insurance does not cover breast massage or international board-certified lactation consultants; therefore, these women were not included in the study.
This study was designed to explore the prescription of TCM for mastitis in Taiwan. We found that certain Chinese medicines have anti-inflammation and analgesic effects for treating mastitis, similar to Western medicine. Furthermore, Chinese medicine rarely causes stomach pain, diarrhoea, or indigestion and may be a possible alternative for treating mastitis.
5. Limitations
There are two limitations to this study. First, due to the feature of the LHID, we could not differentiate the aetiology of mastitis. Nevertheless, the 10 most prescribed CHM products were compliant with the clinical treatment of lactation mastitis. Second, mastitis is diagnosed by clinical symptoms and signs, and most patients had a good prognosis after receiving appropriate treatment, so it is hard to evaluate the efficacy of the treatment.
6. Future Perspectives and Priorities
This study discussed the prescription patterns of Chinese herbal medicine products in women with mastitis in Taiwan. However, a well-conducted, randomized controlled trial should be conducted to further evaluate the efficacy of TCM treatment for mastitis.
7. Conclusions
The present study provides preliminary clinical evidence supporting the prescription patterns of CHM products in women with mastitis. Approximately 5.1% of women with mastitis received CHM as complementary treatment. Xian-Fang-Huo-Ming-Yin is the most frequently prescribed Chinese herbal formula in these cases. Further well-designed, clinical trials could be developed to evaluate the effectiveness of TCM for mastitis.
Acknowledgments
This study is based in part on data from the National Health Insurance Research Database, provided by the National Health Insurance Administration and Ministry of Health and Welfare and managed by National Health Research Institutes.
Abbreviations
- CHM:
Chinese herbal medicine
- ICD-9-CM:
International Classification of Diseases, 9th Revision, Clinical Modification
- LHID:
Longitudinal Health Insurance Database
- NHIRD:
National Health Insurance Research Database
- TCM:
Traditional Chinese medicine
- TWD:
Taiwan dollars.
Data Availability
The data used to support the findings of this study are included within the article.
Conflicts of Interest
The authors declare that there are no conflicts of interest.
Authors' Contributions
SHC designed the study, and PJC supervised the project. CCH performed the data analysis. SHC drafted the manuscript. PJC, CCH, CHL, and KCW gave feedback on the manuscript.
References
- 1.World Health Organization. Geneva, Switzerland: World Health Organization; 2000. Mastitis: causes and management. https://www.who.int/maternal_child_adolescent/documents/fch_cah_00_13/en/ [Google Scholar]
- 2.Amir L. H. Academy of breastfeeding medicine protocol C. ABM clinical protocol #4: mastitis, revised March 2014. Breastfeeding Medicine . 2014;9(5):239–243. doi: 10.1089/bfm.2014.9984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Blackmon M. M., Nguyen H., Mukherji P. Acute Mastitis . Treasure Island, FL, USA: StatPearls; 2021. [PubMed] [Google Scholar]
- 4.Gopalakrishnan Nair C., Hiran, Jacob P., Menon R. R., Misha Inflammatory diseases of the non-lactating female breasts. International Journal of Surgery . 2015;13:8–11. doi: 10.1016/j.ijsu.2014.11.022. [DOI] [PubMed] [Google Scholar]
- 5.Foxman B., D’Arcy H., Gillespie B., Bobo J. K., Schwartz K. Lactation mastitis: occurrence and medical management among 946 breastfeeding women in the United States. American Journal of Epidemiology . 2002;155(2):103–14. doi: 10.1093/aje/155.2.103. [DOI] [PubMed] [Google Scholar]
- 6.Barbosa-Cesnik C., Schwartz K., Foxman B. Lactation mastitis. Journal of American Medical Association . 2003;289(13):1609–1612. doi: 10.1001/jama.289.13.1609. [DOI] [PubMed] [Google Scholar]
- 7.El-Saidy T. M. K., Aboushady R. M.-N. Effect of two different nursing care approaches on reduction of breast engorgement among postnatal women. Journal of Nursing Education and Practice . 2016;6(9):18–28. doi: 10.5430/jnep.v6n9p18. [DOI] [Google Scholar]
- 8.Wu D., Zhang X., Liu L., Guo Y., Key C. M. M. Combinations in prescriptions for treating mastitis and working mechanism analysis based on network pharmacology. Evidence-based Complementary and Alternative Medicine . 2019;2019:11. doi: 10.1155/2019/8245071.8245071 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Maciocia G. Obstetrics and Gynecology in Chinese Medicine . 2nd. New York, NY, USA: Churchill Livingstone; 2011. [Google Scholar]
- 10.Chen M. H., Chen X. J., Wang M., Lin L. G., Wang Y. T. Ophiopogon japonicus—a phytochemical, ethnomedicinal and pharmacological review. Journal of Ethnopharmacology . 2016;181:193–213. doi: 10.1016/j.jep.2016.01.037. [DOI] [PubMed] [Google Scholar]
- 11.Schütz K., Carle R., Schieber A. Taraxacum—a review on its phytochemical and pharmacological profile. Journal of Ethnopharmacology . 2006;107(3):313–323. doi: 10.1016/j.jep.2006.07.021. [DOI] [PubMed] [Google Scholar]
- 12.Wang L., Cui D., Wang X., et al. Analgesic and anti-inflammatory effects of hydroalcoholic extract isolated from semen vaccariae. Pakistan Journal of Pharmaceutical Sciences . 2015;28(3):1043–1048. [PubMed] [Google Scholar]
- 13.Sun Y., Xu X., Zhang J., Chen Y. Treatment of depression with Chai Hu Shu Gan San: a systematic review and meta-analysis of 42 randomized controlled trials. BMC Complementary and Alternative Medicine . 2018;18(1):p. 66. doi: 10.1186/s12906-018-2130-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Xie F., Zhang M., Zhang C. F., Wang Z. T., Yu B. Y., Kou J. P. Anti-inflammatory and analgesic activities of ethanolic extract and two limonoids from Melia toosendan fruit. Journal of Ethnopharmacology . 2008;117(3):463–466. doi: 10.1016/j.jep.2008.02.025. [DOI] [PubMed] [Google Scholar]
- 15.Hua K. F., Yang T. J., Chiu H. W., Ho C. L. Essential oil from leaves of liquidambar formosana ameliorates inflammatory response in lipopolysaccharide-activated mouse macrophages. Natural Product Communications . 2014;9(6):869–872. doi: 10.1177/1934578x1400900638. [DOI] [PubMed] [Google Scholar]
- 16.Zhou Y., Xie M., Song Y., et al. Two traditional Chinese medicines Curcumae radix and Curcumae rhizoma: an ethnopharmacology, phytochemistry, and pharmacology review. Evidence-based Complementary and Alternative Medicine . 2016;2016:30. doi: 10.1155/2016/4973128.4973128 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Lim R. J., Nik Nabil W. N., Chan S. Y., et al. Effects of herbal medicine for xerostomia in head and neck cancer patients: an observational study in a tertiary cancer hospital. Supportive Care in Cancer . 2019;27(9):3491–3498. doi: 10.1007/s00520-019-4646-2. [DOI] [PubMed] [Google Scholar]
- 18.Cho I. H., Lee M. J., Kim J. H., et al. Fritillaria ussuriensis extract inhibits the production of inflammatory cytokine and MAPKs in mast cells. Bioscience, Biotechnology, and Biochemistry . 2011;75(8):1440–1445. doi: 10.1271/bbb.110076. [DOI] [PubMed] [Google Scholar]
- 19.Li T., Peng T. Traditional e medicine as a source of molecules with antiviral activity. Antiviral Research . 2013;97(1):1–9. doi: 10.1016/j.antiviral.2012.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Health Promotion Administration. Taipei, Taiwan: Health Promotion Administration; 2018. 2018 annual report of health promotion administration. https://www.hpa.gov.tw/Pages/List.aspx?nodeid=1248/ [Google Scholar]
- 21.Cheon C., Kang S., Ko Y., et al. Single-arm, open-label, dose-escalation phase I study to evaluate the safety of a herbal medicine SH003 in patients with solid cancer: a study protocol. BMJ Open . 2018;8(8) doi: 10.1136/bmjopen-2017-019502.e019502 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Hunt K. M., Williams J. E., Shafii B., et al. Mastitis is associated with increased free fatty acids, somatic cell count, and interleukin-8 concentrations in human milk. Breastfeeding Medicine: The Official Journal of the Academy of Breastfeeding Medicine . 2013;8(1):105–110. doi: 10.1089/bfm.2011.0141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Pantel S., Chin S. Y. Proceedings of the Workshop On Trade and Conservation Of Pangolins Native to South and Southeast Asia; 2009; Petaling Jaya, Malaysia. [Google Scholar]
- 24.Hsieh C.-C. The lactation performance, immunomodulation and antitumor effects in the replacement drugs of Squama Manitis. Yearbook of Chinese Medicine and Pharmacy . 2005;23(5):93–126. [Google Scholar]
- 25.National Geographic Society. Washington, DC, USA: National Geographic Society; 2018. Will mainstreaming traditional Chinese medicine threaten wildlife? https://www.nationalgeographic.com/animals/2018/12/traditional-medicine-decision-threatens-wildlife/ [Google Scholar]
- 26.Chen Y. L., Lee C. Y., Huang K. H., Kuan Y. H., Chen M. Prescription patterns of Chinese herbal products for patients with sleep disorder and major depressive disorder in Taiwan. Journal of Ethnopharmacology . 2015;171:307–16. doi: 10.1016/j.jep.2015.05.045. [DOI] [PubMed] [Google Scholar]
- 27.Park D. M., Kim S. H., Park Y. C., Kang W. C., Lee S. R., Jung I. C. The comparative clinical study of efficacy of Gamisoyo-San (Jiaweixiaoyaosan) on generalized anxiety disorder according to differently manufactured preparations: multicenter, randomized, double blind, placebo controlled trial. Journal of Ethnopharmacology . 2014;158:11–17. doi: 10.1016/j.jep.2014.10.024. [DOI] [PubMed] [Google Scholar]
- 28.Yasui T., Yamada M., Uemura H., et al. Changes in circulating cytokine levels in midlife women with psychological symptoms with selective serotonin reuptake inhibitor and Japanese traditional medicine. Maturitas . 2009;62(2):146–52. doi: 10.1016/j.maturitas.2008.12.007. [DOI] [PubMed] [Google Scholar]
- 29.Zhang S., Liu X., Sun M., et al. Reversal of reserpine-induced depression and cognitive disorder in zebrafish by sertraline and Traditional Chinese Medicine (TCM) Behavioral and Brain Functions: BBF . 2018;14(1):p. 13. doi: 10.1186/s12993-018-0145-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Chen S., Asakawa T., Ding S., et al. Chaihu-Shugan-San administration ameliorates perimenopausal anxiety and depression in rats. PLoS One . 2013;8(8) doi: 10.1371/journal.pone.0072428.e72428 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Cooklin A. R., Amir L. H., Nguyen C. D., et al. Physical health, breastfeeding problems and maternal mood in the early postpartum: a prospective cohort study. Archives of Women’s Mental Health . 2018;21(3):365–374. doi: 10.1007/s00737-017-0805-y. [DOI] [PubMed] [Google Scholar]
- 32.Fallon V., Groves R., Halford J. C., Bennett K. M., Harrold J. A. Postpartum anxiety and infant-feeding outcomes. Journal of Human Lactation . 2016;32(4):740–758. doi: 10.1177/0890334416662241. [DOI] [PubMed] [Google Scholar]
- 33.Webber E., Benedict J. Postpartum depression: a multi-disciplinary approach to screening, management and breastfeeding support. Archives of Psychiatric Nursing . 2019;33(3):284–289. doi: 10.1016/j.apnu.2019.01.008. [DOI] [PubMed] [Google Scholar]
- 34.Fang J., Wang X., Lu M., He X., Yang X. Recent advances in polysaccharides from Ophiopogon japonicus and Liriope spicata var. prolifera. International Journal of Biological Macromolecules . 2018;114:1257–1266. doi: 10.1016/j.ijbiomac.2018.04.022. [DOI] [PubMed] [Google Scholar]
- 35.Kuo S. H., Wang H. L., Lee T. C., et al. Traditional Chinese medicine perspective on constitution transformations in perinatal women: a prospective longitudinal study. Women and Birth: Journal of the Australian College of Midwives . 2015;28(2):106–111. doi: 10.1016/j.wombi.2015.01.002. [DOI] [PubMed] [Google Scholar]
- 36.Gjerdingen D. K., Froberg D. G., Chaloner K. M., McGovern P. M. Changes in women’s physical health during the first postpartum year. Archives of Family Medicine . 1993;2(3):277–283. doi: 10.1001/archfami.2.3.277. [DOI] [PubMed] [Google Scholar]
- 37.Amabebe E., Robert F. O., Obika L. F. O. Osmoregulatory adaptations during lactation: thirst, arginine vasopressin and plasma osmolality responses. Nigerian Journal of Physiological Sciences: Official Publication of the Physiological Society of Nigeria . 2017;32(2):109–116. [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data used to support the findings of this study are included within the article.